Jeffrey B. Driban, PhD, answers our questions about his study that evaluated whether infrapatellar fat pad signal intensity alteration and greater effusion-synovitis volume can differentiate adults who will...
A new study examined the effects of SBP and DBP on cardiovascular outcomes in light of recently revised hypertension guidelines. Lead author Alexander Flint, MD, PhD, answers our questions about his study.
...
Though current guidelines recommend antiplatelet therapy for patients with cryptogenic stroke, new research is examining the effect of anticoagulation therapy on patient outcomes. Researcher Hooman Kamel,...
Florian Rieder, MD, from Cleveland Clinic, answers our questions about the current management of strictures in Crohn disease, the need for antifibrotic medications, and more.
A study being presented at the ANA 2019 annual meeting highlights the connection between primary progressive aphasia and Alzheimer disease. Speaker and lead researcher Marek-Marsel Mesulam, MD, answers our...
Psych Congress cochair Charles Raison, MD, sees big changes coming in the treatment of depression. Here, he discusses the problems which can result from long-term antidepressant treatment.
Shivani Garg, MD, from The University of Wisconsin School of Medicine and Public Health, answers our questions about her research on improving pneumococcal vaccination rates among patients with systemic...
In a systematic review, Richard Brindle, MD, and colleagues investigated whether certain antibiotics, routes of administration, and/or treatment duration affected treatment outcomes among patients with...
In this Q&A, Jason S. Bradfield, MD, answers our questions about his research on epicardial ablation of ventricular tachycardia and the challenges it currently presents.
Scott D. Newsome, DO, from Johns Hopkins Medicine, answers our questions about new multiple sclerosis disease-modifying therapies, the challenges associated with prescribing these therapies, and more.
